Health and population

Health and population dynamics are intertwined, embodying an intricate relationship with significant implications on the Sustainable Development Goals (SDGs). Health is fundamentally at the center of these 17 global goals, aimed to transform the world by 2030. Specifically, Goal 3 endeavors to "Ensure healthy lives and promote well-being for all at all ages." It acknowledges that health is pivotal to human life quality, social cohesion, and sustainable development. Inextricably linked to this are the complexities of population dynamics, including growth rates, age structure, fertility and mortality rates, and migration patterns.

With the world's population projected to exceed 9.7 billion by 2050, the pressure on health systems will undoubtedly escalate. The demographic transition, with an aging population and an increasing prevalence of non-communicable diseases, poses new challenges for health systems globally. Additionally, areas with high fertility rates often overlap with extreme poverty, resulting in heightened health risks, including higher maternal and child mortality rates, malnutrition, and infectious diseases.

Moreover, rapid urbanization and migration present both opportunities and threats to health. While urban areas may provide better access to healthcare, they also harbor risks of disease transmission, air and water pollution, and social determinants of health like inadequate housing and social inequality. Simultaneously, migrants often face disproportionate health risks due to unstable living conditions, exploitation, and limited access to healthcare services.

Achieving the SDGs will necessitate comprehensive approaches that consider the intricate interplay of health and population dynamics. It means strengthening health systems, promoting universal health coverage, and addressing social determinants of health. It also implies crafting policies that recognize demographic realities and foster an environment conducive to sustainable development. Only by understanding and harnessing these dynamics can the world meaningfully progress towards realizing the SDGs, ensuring healthy lives and well-being for all.

This book chapter advances SDG 3 and 10 by reviewing the literature on culture and family-based psychological interventions for schizophrenia, bipolar, and related (SBR) psychotic spectrum disorder.
Elsevier,

Diagnosis and Management in Dementia, Volume 1, August 2020, Pages 3-15

This book chapter advances SDGs 3 and 17 by reviewing how to diagnosis mixed dementias.
Elsevier,

Diagnosis and Management in Dementia, Volume 1, August 2020, Pages 665-680

This book chapter advances SDGs 3 and 17 by describing how acute hospital settings can affect the care of patients with dementia. As well as changes to the physical hospital environment, this requires an enhanced focus on key strategies such as reliable identification of cognitive impairment, access to comprehensive geriatric assessment, prevention and management of delirium, and timely discharge planning are included in the chapter.
This book chapter advances SDGs 3 and 17 by reviewing pathological and functional outcomes of both preventative and therapeutic environmental enrichment on commonly used mouse models of amyloid pathology.
Elsevier,

Diagnosis and Management in Dementia, Volume 1, August 2020, Pages 827-842

This book chapter advances SDGs 3 and 17 by discussing the potential impact of dementia on creativity, physical activity, and exercise participation and whether exercise and creativity may each exert individual effects on the maintenance and/or facilitation of cognitive health. This chapter explores the context of biological and theoretical mechanisms underlying dementia and provide recommendations for future research experiments unifying physical exercise and creative activities into tailored interventions designed to better comprehend this disease and perhaps counteract the devastating implications dementia prognoses present to optimal physical and mental functioning across the human life span.
Elsevier,

Diagnosis and Management in Dementia, Volume 1, August 2020, Pages 127-146

This book chapter advances SDGs 3 and 17 by focusing on providing a brief overview of genes associated with sporadic (late-onset) Alzheimer's disease (AD). Despite decades of research, no current and reliable test is currently available for the diagnosis of AD. Genetic biomarkers are promising for both diagnostic tools and tailored profiling therapy.
This book chapter advances SDGs 3 and 17 by discussing available data regarding the effects of genetic variants on the clinical and pathological characteristics of “frontotemporal dementia” (FTD). The term “frontotemporal dementia” (FTD) defines a group of related diseases resulting from progressive degeneration of the temporal and frontal lobes. These areas play a significant role in decision-making, behavioral control, emotion, language, and motor functions.
This Research Paper supports SDG 3 by demonstrating that the use of rapid whole-exome sequencing to detect rare genetic diseases can reduce health-care expenditure and achieve net healthcare cost-savings in clinical settings in Hong Kong.
A Commission on dementia prevention, intervention, and care, in the context of SDG 3, focusing specifically on individual-level and policy-level interventions for modifying risk factors to prevent or delay onset, tackling inequalities, providing holistic post-diagnostic care, managing neuropsychiatric symptoms, and caring for family carers.
Elsevier,

The Lancet, Volume 396, Issue 10247, 1–7 August 2020, Pages 301-302

This news report addresses SDGs 3 and 5 by highlighting how the COVID-19 pandemic has led to a global surge in violence against women and girls. The report highlights that lack of access to sexual and reproductive health services during the lockdown and thereafter could result in up to 7 million unintended pregnancies worldwide, and up to 2·7 million unsafe abortions and 11 000 pregnancy-related deaths.

Pages